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The proliferation, differentiation, and fusion of a small number of myogenic precursor cells must be precisely regulated
during development to ensure the proper size, organization, and function of the limb musculature. We have examined the
role of Sonic hedgehog (Shh) in these processes by both augmentation and inhibition of the Shh-mediated signaling pathway.
Our data show that Shh regulates muscle development by repressing the terminal differentiation of early myogenic
precursor cells and does not function as a myoblast mitogen. Shh function in hypaxial muscle appears to be spatially
restricted to the early myoblast population within the ventral muscles of the posterior region of the limb. Furthermore, Shh
appears to act as a permissive, rather than an inductive, signal for slow MyHC expression in myoblasts. Our data thus provide
the foundation for a new hypothesis for Shh function in hypaxial skeletal muscle development. © 2002 Elsevier Science (USA)
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Lineage studies have shown that the majority of myo-
genic cells forming the striated skeletal muscle of the
vertebrate body originate from the somites (for reviews, see
Arnold and Braun, 2000; Christ and Ordahl, 1995; Stockdale
et al., 2000). The dorsal region of the somites matures to
form the dermamyotome, which gives rise to muscle and
dermis. Cells from the dorsomedial region of the somite
migrate under the dermamyotome to form the myotome
that later gives rise to epaxial muscle and the intercostal
and deep back muscles, while cells from the lateral der-
mamyotome give rise to the hypaxial muscle, the ventral
body wall muscles, and the migrating precursor limb skel-
etal muscle cells (Denetclaw et al., 1997; Kahane et al.,
1998; Ordahl and Le Douarin, 1992; Williams and Ordahl,
1997). While the cells of the myotome express members of
the myogenic regulatory family, including myoD and myf5,
and are postmitotic, the cells at the ventrolateral region of
the somite delay the expression of MRFs and are main-
tained in an undifferentiated state (Ordahl and Le Douarin,
1992). Bmp4, a diffusible signal produced by the lateral
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130plate, has been shown to inhibit terminal muscle differen-
tiation of these prospective hypaxial muscle cells (Pourquie
et al., 1996). At the limb level, these undifferentiated
muscle cells, expressing markers including Pax3 and Msx1
(Bendall et al., 1999; Goulding et al., 1994; Houzelstein et
al., 1999; Williams and Ordahl, 1994), migrate into the
prospective limb buds, where they aggregate into the dorsal
and ventral muscle masses (Schramm and Solursh, 1990).
The cells in the muscle masses undergo massive prolifera-
tion prior to their terminal differentiation and subsequent
fusion into multinucleated myofibers. Several types of
muscle fibers, including slow, slow/fast, and fast, are gen-
erated during myogenesis. These different fibers are char-
acterized according to their myosin heavy chain (MyHC)
isoform expression pattern, which in turn determines the
contraction speeds, metabolic activities, morphology, and
innervation of the individual fibers (for reviews, see Hughes
and Salinas, 1999; Stockdale, 1992). In amniotes, the pro-
cess of myoblast proliferation, differentiation, and fusion
into myofibers occurs in two developmentally distinct
waves. In the first wave, the primary myoblasts fuse to form
primary fibers and primarily express slow MyHCs, while
the second wave of myoblasts fuse to form the secondary
fibers that primarily express fast MyHCs (Kelly and Rubin-
stein, 1980).
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131Shh Inhibition of Limb Myoblast DifferentiationRecent studies of signaling molecules and mechanisms
involved in the regulation of proliferation and differentia-
tion of the limb have focused on Sonic Hedgehog (Shh). The
active Shh molecule is produced via autoprocessing and can
be secreted following cholesterol modification at the N
terminus (Porter et al., 1996). Shh binds to a transmem-
brane receptor, Patched (Ptc), that regulates the activity of
Smoothened (Smo) (Alcedo et al., 1996; Ingham et al., 1991;
Marigo et al., 1996a; Marigo and Tabin, 1996; Stone et al.,
1996). The binding of Shh to Ptc is thought to relieve
Ptc-mediated inhibition of Smo activity, resulting in the
activation of Shh transcription target genes by the Gli
family of transcription factors (Alcedo et al., 1996; Hooper
and Scott, 1989; Marigo et al., 1996b,c; Nakano et al., 1989;
van den Heuvel and Ingham, 1996). Shh is expressed in
embryonic structures such as the notochord, the floor plate
of the neural tube, and the zone of polarizing activity (ZPA),
a posterior region of the developing limb, where it plays
vital roles in determining cell fate and patterning decisions
in the developing embryo (Chang et al., 1994; Chiang et al.,
1996; Echelard et al., 1993; Johnson and Tabin, 1995; Krauss
et al., 1993; Riddle et al., 1993; Roelink et al., 1994).
In the somite, Shh is both a necessary and sufficient
signaling molecule for myoD activation (Borycki et al.,
1998). Recent reports addressing the role of Shh in myogen-
esis have yielded conflicting results as to the precise role of
Shh in hypaxial skeletal muscle development. While some
groups have reported that Shh can induce the proliferation
of limb skeletal muscle cells (Duprez et al., 1998), others
have concluded that Shh can increase muscle mass by
acting as a survival factor for the hypaxial muscle lineage in
vivo and stimulating myogenic differentiation in culture
(Kruger et al., 2001).
In the present study we sought to (i) elucidate the role of
Shh in hypaxial myogenesis in the developing chick em-
bryo, (ii) determine the spatial specificity of Shh for myo-
blasts, and (iii) identify whether a subpopulation of Shh-
responsive hypaxial myoblasts existed. In contrast to
previous studies, we found that Shh does not act as a
muscle-specific mitogen, instead, Shh acts directly to re-
press terminal differentiation of a spatially distinct sub-
population of embryonic myoblasts that will express slow
MyHC. These data explain how Shh appears to act as an
inducer of skeletal muscle tissue, a myoblast mitogen, and
a myoblast survival factor. Our model thus provides a
hypothesis for the role of Shh in hypaxial muscle develop-
ment that is consistent with the timing and the spatial
extent of Shh expression in the early limb.
MATERIALS AND METHODS
Embryos
Fertilized White Leghorn chick embryos were purchased from
SPAFAS (North Franklin, CT). Embryos were incubated at 99.8°F
with constant 55% humidity. Embryos were staged according to
Hamburger and Hamilton (HH) (1951). Unless otherwise noted,
© 2002 Elsevier Science (USAembryos were windowed at HH stage 17 and virus was injected into
the newly formed hind limb bud. Injections were performed using
a Picospritzer (General Valve Corporation).
Viral Constructs and Production
Full-length chick Gli-1 (provided by Dr. Cliff Tabin) was used as
a template to generate mGli-1-myc using the forward primer
containing a ClaI restriction site, 59-CCATCGATGGACCAT-
GTTCAACCC, and the reverse primer that contained a myc tag
(Evan et al., 1985; Munro and Pelham, 1984), a stop codon, and a
ClaI restriction enzyme site, 59-CCATCGATGGCTACAAAT-
CTTCTTCAGAAATCAACTTTTGTTCCAGTGCA.
PCR cycles of 94°C (1 min) and 30 cycles of 94°C (1 min), 65°C
(1 min), and 72°C (1 min) resulted in a 1.3-kb fragment, which was
isolated from a 0.7% agarose gel and purified using QIAEX II Gel
Extraction Kit (Qiagen). This fragment was subcloned into pBlue-
script II SK (1/2) (Stratagene). The ClaI fragment of pBSK-mGli-1-
myc was subcloned into RCAS-BP-A (RCAS-BP-A-mGli-1-myc)
and sequenced to identify possible mutations and to identify clones
with the appropriate orientation. Full-length Shh was cloned into
cla-12 shuttle vector (provided by Dr. Stephen Hughes). The ClaI
fragment of cla12-Shh was subcloned into RCAS-BP-B (RCAS-BP-
B-Shh) and sequenced to identify clones with the appropriate
orientation.
Primary chicken embryo fibroblasts (CEFs) were isolated from
ED12 chick embryos and grown as previously described (Flanagan-
Street et al., 2000). CEFs were transfected with the viral con-
struct RCAS-BP-A-mGli-1-myc, RCAS-BP-B-Shh, or RCAS-BP-A-
Shh (provided by Dr. Cliff Tabin), or RCAN and virus were isolated
as previously described (Flanagan-Steet et al., 2000). Shh was
cloned into RCAS-BP-B to allow for co-infection with RCAS-BP-A-
mGli-1. Since the RCAS-BP-B-Shh construct was used in the
control experiment, all subsequent assays were carried out using
this construct. All experiments (with the exception of Figs. 1D–1F)
were repeated with RCAS-BP-A-Shh. No changes or deviations
were observed between the use of RCAS-BP-B-Shh or RCAS-BP-A-
Shh. RCAN is an avian-specific empty retroviral vector used as a
negative control.
Whole-Mount Immunohistochemistry
The AMV-3C2 antibody [Developmental Studies Hybridoma
Bank (Potts et al., 1987)] recognizes avian myoblastosis virus gag
protein p19 and was used to detect RCAS-infected cells in embryos.
A monoclonal anti-myosin antibody, MF20 [Developmental Stud-
ies Hybridoma Bank (Bader et al., 1982)], was used to stain
differentiated skeletal muscle. The AMV-3C2 and MF20 antibodies
were visualized using a goat anti-mouse IgG-horseradish peroxi-
dase (HRP) conjugate secondary antibody (Promega Corp.). Second-
ary antibodies conjugated to HRP were visualized by incubation
with 3,39-diaminobenzidine (DAB) substrate (DAB Peroxidase Sub-
strate Kit; Vector Laboratories).
Whole embryos were harvested at ED6, ED8, and ED10 in cold
13 phosphate-buffered saline (PBS). Embryos were fixed with 4%
paraformaldehyde (PFA) at 4°C for 12 h, washed with PBS, and
bleached in Dent’s Bleach [1 part H2O2:2 parts Dent’s fixative (1
part DMSO:4 parts MeOH)] for 24 h at 4°C, and then rinsed with
MeOH and fixed in Dent’s fixative for 24 h at 4°C. After washing
for 3 h with PBS, the embryos were incubated in primary antibody
that was diluted in blocking solution [5% goat serum, 20%
dimethyl sulfoxide (DMSO)] for 18 h at room temperature. Em-
). All rights reserved.
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room-temperature incubation with secondary antibody that was
diluted in blocking solution. The embryos were then washed for 5 h
with PBS and antibody staining was visualized using a DAB
substrate according to the manufacturer’s instructions (DAB Per-
oxidase Substrate Kit; Vector Laboratories).
Section Immunohistochemistry
Embryos were harvested in cold PBS, then fixed with 4%
paraformaldehyde at 4°C for 12 h and washed with PBS before being
incubated in 15% sucrose for 12 h followed by incubation in 30%
sucrose for 12 h. Embryos were then embedded in OCT (Tissue
Tek) and sectioned at 8–10 mm using a cryostat instrument (Leica).
Slides containing sections were washed with PBS to remove OCT,
then blocked with 5% goat serum and 0.1% Triton X-100 for 1 h at
room temperature. Sections were then incubated in primary anti-
PH3 antibody (Upstate Biotechnology; 1:200) and anti-desmin
supernatant [Developmental Studies Hybridoma Bank (Ip et al.,
1983); 1:2] for 1 h at 37°C, and washed three times for 30 min with
blocking solution at room temperature. Sections were then incubated
in secondary antibodies Alexa Fluor 594-conjugated goat anti-rabbit
(Molecular Probes; 1:500) and FITC-conjugated goat anti-mouse (Pro-
mega Corp.; 1:100) for 1 h at room temperature to detect PH3 and
desmin staining, respectively. Coverslips were mounted over sec-
tions using Vectashield fluorescent mount media containing 49,6-
diamidino-2-phenylindole (DAPI; Vector Laboratories).
To assess slow and fast MyHC expression in vivo, embryos were
injected at HH stage 17 with either RCAS-Shh or RCAS-mGli-1,
harvested at ED10 or ED8, respectively, sectioned (as described
above), and stained with anti-fast (F59) and anti-slow (S58) MyHC
antibodies (these antibodies were provided by Dr. Frank Stockdale
and were used as described by Crow and Stockdale, 1986).
Whole-Mount in Situ
Embryos were harvested at stages specified in text and fixed in
4% paraformaldehyde at 4°C for 12 h. Whole-mount in situ
hybridization was performed as previously described (Wilkinson,
1992) with the following exception. Older embryos (HH 26–27)
were treated with 40 mg/ml Proteinase K for 15 min at room
temperature. Digoxigenin (DIG)-labeled riboprobes were made as
previously described (Wilkinson, 1992). Plasmids used to generate
cShh, and cPtc DIG-labeled riboprobes for in situ hybridization
were provided by Dr. Cliff Tabin. Plasmids used to generate cMyoD
DIG-labeled riboprobes for in situ hybridization were provided by
Dr. Bruce Paterson.
Primary Skeletal Muscle Cell Culture
Primary muscle cells were isolated from hind limb muscle at
stages specified in the text. The muscle tissue was minced,
triturated in 0.1% collagenase, and incubated in a 37°C water bath
for 20 min. After enzymatic digest, the tissue was first passed
through a 21G needle and then through a 40 mm Falcon cell
strainer. The resulting cells were preplated on an uncoated tissue
culture plate and incubated at 37°C for 20 min. The unattached
myoblasts were then harvested, counted using a hemocytometer,
and plated at clonal density (500 cells per 35-mm well) on gelatin-
coated coverslips. Cells were grown in F12 media (GibcoBRL)
containing 15% horse serum (Sigma); 2% chick serum, and 2.5%
chicken embryo extract for 3 days at 37°C. At the end of this
© 2002 Elsevier Science (USAincubation, bromodeoxyuridine (BrdU) was added to the culture
medium at a final concentration of 10 mM for 1 h. The coverslips
were then washed with cold PBS and the cells were fixed with 4%
paraformaldehyde for 10 min at room temperature. The cells were
permeabilized with 0.2% Triton X-100 for 5 min at room tempera-
ture, washed with PBS, and acid treated with 2 N HCl for 1 h at
room temperature. The coverslips were then extensively washed
with PBS until neutral pH was reached, blocked in 5% goat serum,
0.2% Triton X-100 in PBS for 2 h at room temperature, and
incubated with primary antibodies, MF20 (1:10) and anti-BrdU
(Harlen; 1:10) for 1 h at room temperature. Coverslips were then
incubated with secondary antibodies FITC-conjugated goat anti-
mouse (Promega; 1:100) and Texas red-conjugated goat anti-rat
(Jackson Laboratories; 1:100) for 1 h at room temperature to detect
MF20 and BrdU staining, respectively. Coverslips were mounted
onto slides using Vectashield fluorescent mount media containing
DAPI (Vector Laboratories).
In low-serum experiments myoblasts were explanted at ED7
from HH stage 17 RCAS-Shh-infected hind limbs, as previously
described, and plated at mass density (200,000 cells per 35-mm
well). Both infected and control cells were incubated for 2 days
under either full-growth conditions (15% horse serum, 2% chicken
serum, and 2% chicken embryo extract) or low-growth conditions
(3.75% horse serum, 0.5% chicken serum), pulsed for 1 h with 10
mM BrdU, fixed, and costained for BrdU, using anti-BrdU antibody
(Harlen) and a goat polyclonal antibody to desmin (Santa Cruz
Biotechnology). To detect slow and fast MyHC in cultured cells,
embryos were injected with Shh-RCAS at HH stage 17 and the
infected and control myoblasts were explanted at ED7, plated at
mass density (200,000 cells per 35-mm well), and cultured for 2
days under low-growth conditions (3.75% horse serum, 0.5%
chicken serum), fixed, and immunostained with anti-fast (F59) and
anti-slow (S58) MyHC antibodies (these antibodies were provided
by Dr. Frank Stockdale and were used as described by Crow and
Stockdale, 1986).
Skeletal Muscle Wet Mass Determination
Embryos were harvested at ED10 through ED12 in cold PBS. The
left and right hind limbs were removed, using feather germ patterns
as guides, and weighed using an analytical balance. Following
measurement of each whole limb, epidermis and connective tissue
of the limb were removed and the muscle from the limb was
removed from the cartilage/bone elements using No. 5 forceps and
the muscle mass was determined using an analytical balance.
RESULTS
Mutant Gli-1 Blocks Shh Signaling in Embryonic
Myoblasts
To identify a role for Shh in the development of limb
skeletal muscle, we constructed a repressor form of Gli-1 to
block Shh signaling. In Drosophila, a naturally occurring
C-terminal truncated form of Ci (the invertebrate homolog
of the Gli family of transcription factors) acts as a repressor
to block the activity of the full-length Ci (Aza-Blanc et al.,
1997; Chen et al., 1998) and, thus, we engineered a similar
repressor form of Gli-1 by introducing a truncation
C-terminal to its zinc-finger domain. In addition, a myc
epitope tag and a stop codon were introduced approximately
). All rights reserved.
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1A). The mutant Gli-1 (mGli-1) was subcloned into the
RCAS expression vector, and a high titer virus was pro-
duced that expresses high levels of ectopic protein (data not
shown).
To test the ability of mGli-1 to inhibit Shh activity, we
examined the responsiveness of embryonic myoblasts to
Shh before and after mGli-1 infection. Embryos were in-
jected with RCAN (empty retroviral vector) or RCAS-
mGli-1 in the hind limb at HH stage 17, explanted at ED8,
and the number of BrdU- and myosin-positive cells were
determined. RCAN-infected cells were subsequently co-
infected with RCAS-Shh or left untreated. The explanted
RCAN myoblasts, co-infected with RCAS-Shh, exhibit a
55% increase in DNA synthesis compared to that of control
myoblasts (Fig. 1B), similar to previously published data
demonstrating an apparent proliferative effect of Shh on
limb myoblasts (Duprez et al., 1998). Figure 1C shows that
in vivo RCAN infection was efficient and maintained as
determined by an infectivity assay. In this assay myoblasts
from an infected limb are explanted and 4 h later fixed and
stained for expression of a viral coat protein marker. Myo-
blasts infected in vivo with RCAS-mGli-1 followed by
infection of cultured cells with RCAS-Shh show no detect-
able increase in DNA synthesis (Fig. 1D). Both mGli-1 and
Shh are expressed in sequentially infected cells, as indicated
by staining for the myc epitope tag (mGli-1) and Shh (Figs.
1E and 1F). After a 3-day incubation, all infected cells
stained positively with both antibodies. The majority of
Shh staining is punctate and localized to the cell membrane
and extracellular matrix, while mGli-1 staining is present
throughout the cytoplasm and the nucleus (compare Figs.
1E and 1F).
The ability of mGli-1 to inhibit Shh activity in vivo was
demonstrated by assaying embryos infected with mGli-1 for
ptc expression. Ptc was previously shown to be a direct gene
target of Hh signaling and ptc expression can be up-
regulated in response to Shh overexpression (Marigo and
Tabin, 1996; Platt et al., 1997). Embryos injected with
RCAS-mGli-1 in the hind limb at HH stage 17, harvested
48 h later, show a detectable decrease in ptc expression,
compared to that of the contralateral uninjected limb (Figs.
1G and 1H). Thus, our mGli-1 construct appears to block
Shh signaling in myoblasts and in the developing limb.
Ectopic Shh Expression Increases the Pool of
myoD-Positive Embryonic Myoblasts in Vivo
Implantation of beads coated with N-Shh or implantation
of cells expressing Shh induces duplications in limb skel-
etal elements. In addition, N-Shh bead and Shh expressing
cell pellet implantation has been shown to up-regulate
myoD expression and proposed to promote myoblast pro-
liferation, respectively. Since both methods of applying Shh
also dramatically affect skeletogenesis and thus obscure
direct effects on skeletal muscle development (Amthor et
© 2002 Elsevier Science (USAal., 1998; Duprez et al., 1998), we sought to express Shh at
lower levels and at later times allowing skeletal elements to
develop normally. Infection of developing leg buds at HH
stage 17 yields significant propagation of the RCAS-Shh
virus within 72 h, as determined by immunohistochemical
staining for the p19 viral coat protein in control contralat-
eral (Fig. 2A) and infected limbs (Fig. 2B). In the absence of
detectable skeletal effects (at HH stage 27, shown; and
ED12, data not shown), we found that ectopic Shh expres-
sion dramatically increased the number of myoD-express-
ing embryonic myoblasts when contralateral controls (Fig.
2C) were compared to RCAS-Shh-infected limbs (Fig. 2D).
At this developmental stage, the area encompassing myoD-
positive cells appears to increase in both the dorsal (arrow-
head) and ventral (arrow) muscle masses compared to that
of the contralateral control. Thus, embryonic myoblasts
present in both muscle masses at these early stages appear
capable of responding to ectopically expressed Shh.
Inhibition of Shh-Mediated Signaling by mGli-1
Reduces myoD-positive Embryonic Myoblasts
in the Hind Limb
Overexpression of Shh appears to increase the number of
myoD-positive embryonic myoblasts in both the dorsal and
ventral muscle masses. Since the observed results due to
ectopic overexpression of growth factors may be artifacts
due to the nonphysiological levels expressed, we sought to
inhibit Shh-mediated signaling in vivo to determine
whether inhibition of Shh signaling would decrease the
number of myoD-positive embryonic myoblasts compared
to that of control uninfected limbs. We have established
that mGli-1 inhibits Shh function in explanted myoblasts
(Fig. 1) and, therefore, embryos were infected in the poste-
rior region of HH stage 17 hind limbs with RCAS-mGli-1.
The infection was limited to the posterior region of the
limb bud 48 h following injection, as demonstrated by
comparing p19 viral coat protein staining in uninfected (Fig.
3A) and RCAS-mGli-1-infected limbs (Fig. 3B). The number
of myoD-positive embryonic myoblasts appears dramati-
cally reduced following infection with RCAS-mGli-1 when
myoD expression levels in uninfected (Fig. 3C) and infected
limbs (Fig. 3D) are compared. Whole-mount in situ hybrid-
ization with myoD probe reveals a significant loss of myoD
expression area in the ventral muscle mass (arrow) and
relatively little loss in the dorsal muscle mass (arrowhead)
compared to that of contralateral controls (Figs. 3C and 3D).
In contrast to the Shh overexpression results, inhibition of
Shh signaling in the posterior limb bud does not appear to
dramatically affect dorsal muscle cells. Thus, it is possible
that the virus did not sufficiently block Shh responses in
the dorsal muscle mass or endogenous Shh may differen-
tially regulate myogenic precursors in the dorsal and ven-
tral muscle masses.
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134 Bren-Mattison and OlwinFIG. 1. mGli-1 inhibits Shh-mediated signaling. (A) Wild type Gli-1 illustrating the relative positions of the Zn-finger (ZF) and the
activation domain (AD). The mGli-1 construct containing a myc epitope tag and stop codon following the ZF DNA binding domain. (B)
Limb buds were infected with RCAN at HH stage 17, explanted (see Materials and Methods) and subsequently co-infected with
RCAS-B-Shh. BrdU-positive cells were scored for RCAN infected (control) and RCAN/RCAS-Shh sequentially infected clones. The
difference in BrdU-positive cells is quantified as compared to control cells. The data represent three independent experiments with a
minimum of 19 clones scored per experiment. (C) RCAN-infected cells were fixed 4 h following plating and stained with an anti-3C2
antibody, which recognizes a viral coat protein. Approximately 95% of explanted cells stained positively with the 3C2 antibody, indicating
the majority of cells were infected in vivo. (D) Infection of limb buds at HH stage 17 with RCAS-mGli-1 followed by infection with
RCAS-Shh eliminates the response to Shh observed in the absence of mGli-1, demonstrating the ability of mGli-1 to block Shh activity.
(E, F) Cell cultures stained with anti-Shh (green), anti-myc (red) antibodies (E), and DAPI (blue) (F) demonstrate that infected cells express
both Shh and mGli-1. Note that Shh staining is primarily observed extracellularly, whereas the mGli-1 staining is present in the cytoplasm
and the nucleus. (G, H) Embryos injected with RCAS-mGli-1 in the hind limb at HH stage 17, and harvested 48 h later show a decrease in
ptc expression (H), compared to that of the contralateral uninjected limb (G).
135Shh Inhibition of Limb Myoblast DifferentiationFIG. 2. Misexpression of Shh increases the area of myoD expression. Limb buds of HH stage 17 embryos were either untreated (A,
C) or injected with RCAS-Shh in the anterior region (B, D). The embryos were harvested 72 h later and assayed for viral infection by
whole-mount immunohistochemistry (A, B) or processed for whole-mount in situ hybridization with a myoD probe (C, D). Staining
from the 3C2 antibody shows infection and spread of the virus in the anterior region of the leg (B), while the contralateral limb is not
infected (A). Infection with RCAS-Shh increases the myoD-positive expression area in both the dorsal (arrowhead) and ventral (arrow)
muscle masses (D).
FIG. 3. Inhibition of Shh-mediated signaling by mGli-1 causes a reduction in the area of myoD expression. Limb buds of HH stage
17 embryos were either untreated (A, C) or injected with RCAS-mGli-1 in the posterior region (B, D). The embryos were harvested 72
h later and assayed for viral infection spread by whole-mount immunohistochemistry (A, B) or processed for whole-mount in situ
hybridization with a myoD probe (C, D). Staining with the 3C2 antibody shows infection and spread of the virus in the posterior region
of the leg (B), while the contralateral limb is not infected (A). Infection with RCAS-mGli-1 dramatically decreases the myoD
expression area in the ventral muscle masses (D, arrow), but not in the dorsal muscle mass (D, arrowhead).
© 2002 Elsevier Science (USA). All rights reserved.
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Dramatically Affects Skeletal Muscle Mass
without Detectable Effects on Skeletogenesis
Ectopic overexpression of Shh and mGli-1 exhibited re-
ciprocal effects on the size of the myoD-positive expression
area, suggesting that Shh may play a critical role in deter-
mining the pool size of embryonic myoblasts. If ectopic
overexpression of Shh increases the number of embryonic
myoblasts, then we would expect to observe an increase in
skeletal muscle tissue once the majority of cells have
differentiated. Ectopic mGli-1 expression should yield the
opposite phenotype, causing a loss of skeletal muscle tissue
following differentiation of the embryonic myoblasts. Em-
bryos were injected with RCAS-Shh in the entire hind limb
at HH stage 17, or the posterior region of the hind limb bud
FIG. 4. Augmentation or inhibition of Shh signaling causes respec
Limb buds of HH stage 17 embryos were either untreated (A, C) or
RCAS-mGli-1 in the posterior region (D). The embryos were ha
differentiated skeletal muscle marker MyHC protein using a mon
show increased levels of myosin as well as a general increase in mu
infection (D) leads to reduced levels of MyHC by ED8.with RCAS-mGli-1. Embryos infected with Shh-expressing
© 2002 Elsevier Science (USAvirus were harvested at ED9, while mGli-1-infected em-
bryos were harvested at ED8, respectively. Whole-mount
immunohistochemistry using an antibody to myosin heavy
chain (MF20) shows that myosin staining, as well as overall
limb girth are substantially increased in RCAS-Shh-
infected limbs (Fig. 4B) compared to that of contralateral
controls (Fig. 4A). In contrast, limbs ectopically expressing
mGli-1 show a reduction in overall limb girth and a
substantial loss of myosin staining (Fig. 4D) compared to
that of contralateral controls (Fig. 4C) in both the dorsal and
ventral muscles. Of particular interest is the observation
that the majority of the skeletal muscle increase occurs in
the ventral muscles of the lower limb. Specifically, ventral
muscles seemed to be affected to a greater degree than
dorsal muscles by Shh augmentation (Fig. 4). To demon-
increases or decreases in levels of skeletal muscle myosin protein.
cted with RCAS-Shh in the anterior region of the hind limb (B) or
ed at ED9 (RCAS-Shh) and ED8 (RCAS-mGli-1) and assayed for
nal anti-myosin antibody (MF20). At ED9, Shh-infected limbs (B)




sclestrate that the area of infection has sufficiently spread since
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137Shh Inhibition of Limb Myoblast Differentiationthe initial injection, we performed an infectivity assay on
ED10 myoblasts. Cells were explanted from ED10 limbs
infected with either RCAS-Shh or RCAS-mGli-1 and myo-
blasts were isolated and fixed within 4 h after the explant
procedure, effectively eliminating any possibility of new
infection. A minimum of 87% of all explanted skeletal
muscle myoblasts were positive for Shh from RCAS-Shh-
infected limbs and a minimum of 85% were positive for the
myc epitope tag of mGli-1 from RCAS-mGli-1-infected
limbs (data not shown). These data show that nearly all
myoblasts in all regions of the limb are infected by ED10.
The qualitative interpretation of the whole-mount im-
munohistochemical MyHC staining data suggests that in-
creases and decreases in muscle mass will occur upon
ectopic expression of Shh and mGli-1, respectively. A
quantitative analysis of these data was performed by infect-
ing limbs at HH stage 17 with either Shh or mGli-1 and
determining the masses of whole limbs and skeletal
muscle. Both the mass of the whole limb and, to a greater
extent, the removed muscle tissue (see Materials and Meth-
ods) was increased in Shh-infected limbs (Fig. 5). In con-
trast, infection with mGli-1 reduced skeletal muscle and
whole limb mass (Fig. 5). The majority of changes in limb
mass are due to changes in the mass of skeletal muscle
tissue (Figs. 3, 4, and 5). To minimize experimental error, a
large sample size was considered for each data set (Shh, n 5
30; mGli-1, n 5 29; RCAN, n 5 31). We did not detect
observable differences in long bone length or diameter in
ED10–ED12 limbs infected with either Shh- or mGli-1-
expressing viruses (data not shown). These data suggest that
FIG. 5. Manipulating Shh signaling affects skeletal muscle mass.
Embryos were injected at HH stage 17 with RCAS-mGli-1, RCAS-
Shh, or RCAN. Embryos were harvested between E10 and E12.
Injected and contralateral control limbs were weighed (gray bars).
The muscle from the injected and contralateral control limbs was
then removed and weighed (black bars). In three separate experi-
ments the percentage weight differences of the RCAS-mGli-1,
RCAS-Shh, or RCAN injected limbs were calculated relative to
their contralateral control limbs, respectively (set at 0).Shh is an important regulator of the pool of embryonic
© 2002 Elsevier Science (USAmyoblasts. The appropriate level of Shh appears necessary
to maintain the embryonic myoblast pool; an increase or
decrease in Shh signaling dramatically affects the size of
this pool and, subsequently, the muscle mass.
Shh Affects a Spatially Restricted Population of
Embryonic Myoblasts in the Developing Limb
Ectopic overexpression of Shh compared to inhibition of
Shh signaling did not equally affect all skeletal muscles in
ED8–ED9 limbs (Fig. 4). Moreover, this effect is unlikely to
be due to incomplete infection, suggesting that Shh may
regulate a subpopulation of embryonic hypaxial myoblasts.
Also consistent with this hypothesis is the observation that
inhibition of Shh signaling affected embryonic myoD-
positive ventral muscle masses more severely than dorsal
muscle masses (Figs. 3 and 4). Since Shh mRNA is most
strongly expressed in the posterior region of the limb bud,
we asked whether the embryonic hypaxial myoblasts ex-
hibited a spatially restricted response to Shh. Three inde-
pendent experiments were performed to address this ques-
tion. First, we infected the anterior region of HH stage 17
limb buds with RCAS-mGli-1 (Fig. 6A). In contrast to
RCAS-mGli-1 infection of the posterior region of the limb
bud, no detectable change in myoD expression area was
observed when comparing control limbs (Fig. 6C) to RCAS-
mGli-1-infected limbs (Fig. 6D). Infected limbs stained for
the viral coat antigen using the 3C2 antibody confirmed
that viral infection remained confined to the anterior region
of the limb bud after 48 h (Fig. 6B).
As a second test for spatially restricted responsiveness of
embryonic myoblasts, we infected HH stage 17 hindlimbs
with RCAS-mGli-1 in either the anterior or posterior re-
gion. At ED10–ED12, injected and contralateral control
limbs were removed and the limb wet mass was deter-
mined. Following removal of the epidermis and connective
tissue, the muscle from the injected and contralateral limbs
was removed from the cartilage/bone elements and the
muscle mass was determined. Loss of skeletal muscle mass
and limb mass was substantial in the posteriorly mGli-1-
infected limb (Fig. 6E). In marked contrast, infection of the
anterior region caused no significant loss of limb and a
small loss of muscle mass compared to that of contralateral
and RCAN-infected controls (n 5 10; Fig. 6E). We did not
observe deletions or duplications of either the long bones or
distal digits in the hindlimb at ED10–ED12 when embryos
were infected with either RCAS-Shh or RCAS-mGli-1 at
HH stage 17 (data not shown).
The previous experiments suggest that Shh-responsive
ventral muscle myoblasts may be further restricted to the
posterior region of the leg bud. To directly test this, unin-
fected limbs were dissected into approximately equal ante-
rior and posterior halves. Myoblasts from both regions were
explanted, plated at clonal density, and examined for their
responsiveness to exogenously applied Shh (Fig. 7A). Cells
were incubated for 3 days in full-growth media either with
or without RCAS-Shh, pulsed for 1 h with BrdU, fixed, and
). All rights reserved.
138 Bren-Mattison and OlwinFIG. 6. Shh functions in myoblasts restricted to the posterior limb. Embryos were injected with RCAS-mGli-1 in the anterior region of
the hind limb at HH stage 17 (A). These embryos were harvested 48 h later and assayed for viral infection by whole-mount
immunohistochemistry (B). Whole-mount in situ hybridization with an anti-sense myoD probe shows that mGli-1 overexpression in the
anterior region of the limb (D) does not detectably alter myoD mRNA expression compared to that of the control, uninjected limb (C).
RCAS-mGli-1 injected in the anterior of the limb does not cause a large reduction in muscle wet mass. Embryos were injected at HH stage
17 with RCAS-mGli-1 in the anterior region of the hind limb. Embryos were harvested between E10 and E12. Injected and contralateral
control limbs were weighed (gray bars). The muscle from the injected and contralateral control limbs was then removed and weighed
(black bars). The percentage weight differences of the RCAS-mGli-1 injected limbs were calculated relative to their contralateral control
limbs (E).
© 2002 Elsevier Science (USA). All rights reserved.
139Shh Inhibition of Limb Myoblast Differentiationcostained for BrdU and myosin. Myoblasts explanted from
the anterior region of an ED7 limb did not exhibit a
detectable response to Shh, while posterior myoblasts dis-
played a robust Shh response (Fig. 7B). The number of cells
per clone that incorporated BrdU was greatly increased in
the presence of Shh, while the number of differentiated
cells was moderately increased (Fig. 7B). Exposure of ante-
rior myoblasts to Shh had little effect on either DNA
synthesis or differentiation (Fig. 7B). Although the anterior
and posterior regions of the leg bud contain both dorsal and
ventral muscle cells, Shh effects appear to be restricted to
myoblasts located in the posterior limb.
Augmentation or Inhibition of Shh Signaling
in Vivo Directly Affects the Mitotic Index
of Embryonic Myoblasts
Ectopic overexpression of Shh in the developing limb was
FIG. 7. Posterior but not anterior myoblasts are responsive to
Shh. Myoblasts explanted from the anterior region of an ED7 limb
do not respond to Shh. Uninjected hind limbs were harvested at
ED7 and dissected into approximately the anterior and posterior
regions (A). Myoblasts from either region were explanted, plated at
clonal density, and tested for their responsiveness to exogenous
Shh. Cells were incubated for 3 days, pulsed for 1 h with BrdU,
fixed, and stained. The cells were stained with MF20 to detect
differentiated cells and with an antibody to BrdU to detect prolif-
erating cells. The graph quantifies the percentage increase in
proliferating cells/clone and differentiated cells/clone observed
when cultures were infected with RCAS-Shh (B).previously reported to increase myoblast proliferation and
© 2002 Elsevier Science (USAincrease myosin content in the limb. However, the increase
of MyHC accompanied by duplications in skeletal elements
may likely be an indirect result of respecifying limb mes-
enchyme and the skeletal elements (Duprez et al., 1998;
Kruger et al., 2001). Moreover, the reported increases in
myoblast proliferation could result from nonphysiological
levels of ectopically applied Shh. We asked whether increas-
ing or decreasing Shh signaling in the absence of detectable
effects on skeletal elements would alter the numbers of
embryonic myoblasts in vivo. Embryos were infected with
RCAS-Shh in the anterior region of the hind limb or
RCAS-mGli-1 in the posterior region of the hindlimb at HH
stage 17. The embryos were harvested at ED6 and ED8,
sectioned, and costained for desmin, to detect muscle
specific cells, and for phosphorylated histone 3 (PH3), to
detect cells in the M phase of the cell cycle. Costaining of
control limb sections with desmin and PH3 identifies
dividing myoblasts (Figs. 8A and 8B) and revealed a dra-
matic increase in the mitotic index of ED8 embryonic
myoblasts in Shh-infected limbs (Figs. 8C and 8D). Con-
versely, compared to contralateral controls (Figs. 8E and 8F),
overexpression of mGli-1 decreased the mitotic index of
embryonic myoblasts (Figs. 8G and 8H). Quantification of
these data demonstrates that ED6 and ED8 Shh-infected
limbs exhibit a respective increase of 22% and 34% in the
number of dividing desmin-positive cells (Fig. 8I). In con-
trast, mGli-1-infected limbs show a reduction of 25% and
22% in desmin-positive dividing embryonic myoblasts at
ED6 and ED8, respectively (Fig. 8I).
The Extent of Muscle Formation at Early
Developmental Stages Suggests Additional
or Alternate Functions for Shh
If Shh functions as a myoblast mitogen, we would expect
to observe more skeletal MyHC expression at all develop-
mental time points following Shh ectopic expression due to
myoblast expansion and differentiation. Conversely, inhi-
bition of Shh activity would reduce myoblast numbers and
less skeletal MyHC should be observed. While this hypoth-
esis holds true for ED8 and older embryos, an unexpected
phenotype was observed for ED6–ED7 embryos. Staining
for MyHC in ED7 control (Fig. 9A) vs Shh-infected limbs
(Fig. 9B) revealed a decrease in skeletal MyHC in RCAS-
Shh-infected limbs. In contrast to control ED6 limbs (Fig.
9C), limbs ectopically expressing mGli-1 show enhanced
MyHC staining, particularly in the posterior region (Fig.
9D, arrow). These data contradict the data shown in Fig. 4
and the current hypothesis that Shh functions directly as a
mitogen for hypaxial myoblasts.
Shh Is a Repressor of Skeletal Muscle
Differentiation for Embryonic Myoblasts
and Does Not Function as a Mitogen
The Shh-dependent increases in myoblast number and
myoblast mitotic index could arise via three mechanisms
). All rights reserved.
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141Shh Inhibition of Limb Myoblast Differentiationthat may function independently or in concert. Shh could
function as a mitogen for embryonic myoblasts and directly
stimulate DNA synthesis, increasing the mitotic index and
myoblast cell numbers. Alternatively, Shh could function
as a myoblast survival factor, allowing existing prolifera-
tion factors to increase cell numbers without cell death; or,
Shh may function as a repressor of skeletal muscle differ-
entiation, allowing more cells to respond to mitogens
present and expand the population. Our data suggest that
the last hypothesis is more likely, as it would explain the
mGli-1-induced precocious differentiation followed by a
later loss of muscle (Fig. 8). To test this, we infected the
FIG. 8. Shh-mediated signaling affects myoblast mitotic index in
stage 17. These embryos were harvested at ED6 and ED8. Sections
for phosphorylated histone PH3, to detect mitotic cells. Myoblast
than those expressing Shh (C, D). Conversely, control limbs (E, F) d
infected lower hind limbs (G, H). B, D, F, and H show higher magn
the percentage difference in the number of mitotic, desmin-positiv
FIG. 9. mGli-1 causes precocious differentiation, resulting in decr
17 embryos were either untreated (A, C) or injected with RCAS-Sh
embryos were harvested at ED7 (RCAS-Shh) and ED6 (RCAS-mGli
MF20. At ED7, Shh-infected limbs (B) show lower levels of MyHC, w
most notably in the posterior region of the limb.contralateral, uninfected sections at ED6 and ED8 (I).
© 2002 Elsevier Science (USAlimb bud at HH stage 17 with either the RCAS-Shh or the
RCAS-mGli-1, explanted the myoblasts at ED10, and plated
the cells at clonal density. Following a 3-day incubation and
a 1-h BrdU pulse, the cultures were fixed, stained, and
scored for (i) the total number of clones per plate, (ii) the
number of myosin-positive cells per clone, and (iii) the
number of BrdU-positive cells per clone. The total numbers
of myoblast clones from Shh and contralateral limbs were
similar (Fig. 10A). However, Shh-infected clones have a
greater number of cells in each clone undergoing DNA
synthesis and a decrease in differentiated (MyHC-positive)
cells per clone compared to that of contralateral controls
. Embryos were injected with RCAS-Shh in the hind limb at HH
m) were costained for desmin, to detect muscle specific cells, and
feration in control sections (A, B) display fewer PH3-positive cells
more PH3-positive, desmin-positive cells than sections of mGli-1
ions of insets in A, C, E, and G, respectively. The graph represents
lls in Shh- or mGli-1-infected sections relative to their respective
d levels of skeletal muscle myosin protein. Limb buds of HH stage
the hind limb (B) or RCAS-mGli-1 in the posterior region (D). The
d assayed for differentiated skeletal muscle myosin protein using








hile). All rights reserved.
142 Bren-Mattison and Olwin(Fig. 10A). Conversely, mGli-1-infected clones had fewer
cells in S phase, consistent with the previously published
hypothesis that Shh is a myoblast mitogen. Infection with
mGli-1 dramatically increased differentiation and reduced
the number of clones compared to that of contralateral
controls (Fig. 10B), suggesting that Shh may directly affect
differentiation and enhance myoblast survival. The effects
observed are not due to incomplete expression of Shh or
mGli-1 since 87% of the myoblasts from Shh-infected
limbs stained positively for Shh, and 81% of myoblasts
from mGli-1-infected limbs stained positively for the myc
epitope tag (data not shown).
We next sought to test directly the ability of Shh to
promote DNA synthesis and regulate differentiation in
FIG. 10. mGli-1 overexpression results in reduced myoblast pro-
liferation and increased differentiation in vitro. Embryos were
injected with RCAS-Shh in the anterior region of the hind limb at
HH stage 17. Myoblasts from the infected limb and the contralat-
eral control limb were explanted at ED10 and plated at clonal
density. Cells were incubated for 3 days, pulsed for 1 h with BrdU,
fixed, and stained. The cells were stained with MF20, to detect
differentiated cells, and with an antibody to BrdU, to detect cells
synthesizing DNA. The graph quantifies the percent increase in
BrdU-positive cells/clone and the percentage decrease in differen-
tiated cells/clone observed upon infection with Shh (A). Embryos
were injected with RCAS-mGli-1 in the posterior region of the hind
limb at stage HH 17. Myoblasts from the infected limb and the
contralateral control limb were explanted and treated as per RCAS-
Shh experiments in A. The graph quantifies the percentage de-
crease in BrdU-positive cell/clone and the percentage increase in
differentiated cells/clone observed upon infection with mGli-1 (B).embryonic myoblast cultures. Under full-growth condi-
© 2002 Elsevier Science (USAtions, 40% more Shh-expressing myoblasts were also BrdU
positive compared to control contralateral cells (Fig. 11A),
whereas the number of desmin/BrdU-positive cells was
similar to that of contralateral control cells observed under
low-growth conditions, despite ectopic expression of Shh
(Fig. 11A). Thus, Shh is unable to directly stimulate DNA
synthesis in low-growth conditions and it is therefore
unlikely that Shh functions as an embryonic myoblast
mitogen. When we examined the extent of differentiation,
the Shh-infected cells displayed a dramatic and unexpected
decrease in differentiation compared to that of the con-
tralateral control (Fig. 11B). Most important, Shh was able
to repress differentiation under low-growth conditions
where other known repressors of myogenesis such as FGFs
are also active (Fig. 11B). These data identify Shh as a potent
inhibitor of myogenesis and demonstrate that Shh does not
function directly as a myoblast mitogen.
Shh Is Necessary for Appropriate Development
of Slow Skeletal Muscle Fibers
We observed that the effect of Shh on limb skeletal
muscle in vivo is spatially restricted to posterior embryonic
myoblasts in the ventral muscle mass. Since previous
studies in zebrafish have reported that the addition of Shh
peptide to cultured zebrafish myoblasts can induce slow
MyHC expression in a dose-dependent manner (Norris et
al., 2000) we sought to determine whether overexpression
of Shh resulted in increased levels of slow MyHC. Embryos
were injected with Shh-RCAS at HH stage 17; infected and
control myoblasts were explanted at ED8, plated at mass
density, cultured for 2 days in low-growth conditions, fixed,
and immunostained with anti-fast and anti-slow MyHC
antibodies. A dramatic reduction in the differentiation of
myoblasts that will express slow MyHC occurred in Shh-
infected limbs (Fig. 12A) Embryonic myoblasts that will
express fast MyHC were not similarly affected (Fig. 12A).
Together, these data suggest that Shh functions as a potent
repressor of myogenic differentiation that acts preferen-
tially on embryonic myoblasts committed to express slow
MyHC in the muscle mass of the posterior limb.
To test this in vivo, embryos were injected at HH stage 17
with either Shh-RCAS or mGli-1-RCAS, sectioned, and
stained with antibodies that recognize either fast or slow
MyHC isoforms. Control contralateral limbs show a mix-
ture of fast and slow MyHC expression (Fig. 12C) that is
dramatically altered in limbs ectopically expressing Shh
(Fig. 12B). Overexpression of Shh increased the extent of
slow MyHC compared to that of control limbs (compare
Figs. 12B and 12C). Moreover, the pattern of slow MyHC
expression was altered upon Shh overexpression. A pheno-
type was also observed in limbs infected with RCAS-
mGli-1. The pattern was altered for fast vs slow MyHC
staining in control ED8 limbs (Fig. 12E) when compared to
limbs overexpressing mGli-1 (Fig. 12D), where a dramatic
loss of slow MyHC occurred in mGli-1-infected limbs.
These data support the hypothesis that, in vivo, Shh pref-
). All rights reserved.
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containing slow MyHC.
DISCUSSION
The role of Shh in hypaxial muscle development is
controversial. We found, in contrast to previously published
FIG. 11. Shh overexpression does not stimulate DNA synthesis in
low-serum conditions. Embryos were injected with RCAS-Shh in
the anterior region of the hind limb at HH stage 17. Myoblasts from
the infected limb and the contralateral control limb were explanted
at ED7 and plated at mass density. Shh-infected and control cells
were incubated for 2 days under either low- or high-growth condi-
tions, pulsed for 1 h with BrdU, fixed, and stained. The cells were
stained with an anti-desmin antibody, to detect muscle cells, and
with an antibody to BrdU, to detect cells synthesizing DNA. The
graph represents the percentage difference in the number of BrdU-
positive, desmin-positive cells in Shh-infected myoblasts grown
under either low- or high-growth conditions compared to that of
the uninfected control myoblasts, where n, the number of fields, 5
108 (A). The number of myotubes per field was scored to determine
the extent of differentiation. The graph represents the percentage
decrease in the number of myotubes per field in Shh-infected
myoblasts grown under either low-growth conditions or high-
growth conditions compared to that of the uninfected control
myoblasts, where n, the number of fields, 5 108 (B).results, that Shh did not function as a myoblast mitogen but
© 2002 Elsevier Science (USAinstead functions as a potent repressor of embryonic myo-
blast differentiation. Unexpectedly, we found that Shh
inhibits the differentiation of a spatially restricted subset of
skeletal muscle myoblasts located in the posterior region of
the limb bud that preferentially or exclusively are commit-
ted to express slow MyHC. Our model for Shh function in
hypaxial muscle suggests that Shh potently represses differ-
entiation of a committed pool of myogenic precursor cells
that are initially fated to give rise to slow muscle fibers.
Endogenous mitogens regulate the expansion of this pool
and, thus, ectopically applied Shh will disrupt the normal
proliferation and differentiation of this pool by maintaining
undifferentiated precursors inappropriately in both space
and time. Mitogens induce expansion of the Shh-responsive
pool, resulting in an increase of slow myofibers. Inhibition
of Shh signaling removes the inhibitory signals that prevent
differentiation and the myoblasts undergo precocious dif-
ferentiation depleting the precursors and yielding an overall
loss of slow fibers. Taken together, our data provide a model
that explains the previous proliferative activity attributed
to Shh in both mice and chickens (Fig. 13).
Shh Exhibits a Direct Effect on Embryonic
Hypaxial Myoblasts
A direct effect of Shh on hypaxial skeletal muscle myo-
blast proliferation has been reported; however, in the chick,
all Shh studies to date have relied on methods to ectopically
overexpress Shh (Amthor et al., 1996; Duprez et al., 1998).
The high levels of ectopic Shh overexpression resulted in
respecification of the entire limb field and altered skeletal
patterning, which made it difficult to interpret the muscle
phenotype. Similar problems arise when interpreting the
role of Shh on skeletal muscle development in shh2/2 mice,
where gross skeletal patterning alterations may indirectly
affect skeletal muscle precursor cell survival, proliferation,
and differentiation (Kruger et al., 2001). Therefore, we
elected to both augment and inhibit Shh signaling both in
vitro and in vivo using methods that did not affect skeletal
patterning. Our data clearly establish that Shh acts directly
on myoblasts in the developing limb independently of its
role in patterning the limb.
Shh Functions as a Repressor of Myogenesis
An increase in the number of embryonic myoblasts
following overexpression or application of Shh could arise
via several mechanisms including increased survival,
stimulation of proliferation, repression of terminal differen-
tiation, or a combination of these effects. Myoblast mito-
gens and repressors of myogenic differentiation will typi-
cally cause an increase in myoblast cell number in media
containing serum, which has led to the erroneous initial
classification of a number of signaling molecules. FGFs are
incapable of stimulating DNA synthesis of myoblasts in
low-serum-containing media and are thus not myoblast
mitogens but instead repress myogenesis, regulating
). All rights reserved.
144 Bren-Mattison and OlwinFIG. 12. Shh targets the subpopulation of myoblasts committed to express slow MyHC. Embryos were injected with Shh-RCAS at HH
stage 17, and infected and control myoblasts were explanted at ED8 at mass density and cultured for 2 days under low-growth conditions,
fixed, and immunostained with anti-fast and anti-slow MyHC antibodies (F59 and S58, respectively). The graph represents the percentage
decrease in slow and fast MyHC expressing myotubes from Shh-infected cells compared to uninfected cells (A). Embryos were injected at
HH stage 17 with RCAS-Shh or RCAS-mGli-1 and harvested at ED10 or ED8, respectively. Hind limb sections (8 mm) were stained with
antibodies directed to either fast (red) or slow (green) MyHC. Overexpression of Shh increased the extent of slow MyHC compared to that
of control limbs (compare B to C). Conversely, mGli-1 overexpression causes a reduction in the level of slow MyHC expression (D)
compared to that of uninfected contralateral controls (E).
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145Shh Inhibition of Limb Myoblast Differentiationmyogenic differentiation (Clegg et al., 1987; Olwin and
Hauschka, 1986). Shh exhibited no apparent mitogenic activ-
ity in low-growth conditions but was fully capable of repress-
ing terminal differentiation and, thus, acts analogously to
FGFs. Moreover, loss of Shh activity by ectopic mGli-1
overexpression indirectly prevented proliferation by induc-
ing terminal differentiation, further supporting our hypoth-
esis that Shh functions as a repressor of terminal differen-
tiation. Thus, the majority of the effects of Shh can be
attributed to its ability to maintain muscle precursor cells
in an undifferentiated state. Finally, we also observed a
small but detectable effect on Shh on cell survival, suggest-
ing that Shh may also act in part by maintaining cell
survival.
Shh Activity Is Spatially and Functionally
Restricted in Vivo
Shh does not appear to be a repressor of differentiation for
the majority of myoblasts present in the embryonic cell
FIG. 13. Model for Shh function during embryonic hypaxial myob
represses differentiation of posterior myoblasts in the ventral musc
absence of Shh induces precocious differentiation of early myoblas
early stages of development. This precocious differentiation deple
muscle mass due to loss of slow MyHC fibers. Augmentation of
extended period during development, allowing endogenous mitog
MyHC expression at later stages of development and increased mupopulation. Only 10–15% of the total desmin-positive
© 2002 Elsevier Science (USApopulation was affected by Shh. Furthermore, detectable
Shh expression persists in the chicken limb bud only until
Day 7 or Day 8 of development (Riddle et al., 1993), prior to
the appearance of fetal or secondary myoblasts (for review,
see Stockdale, 1992). In addition, the expression pattern of
Shh is concentrated in the posterior mesenchyme of the
developing limb (Riddle et al., 1993) and there is substantial
controversy regarding the distance over which Shh can
signal from its sites of mRNA expression. Thus, the time
and pattern of Shh expression in the limb would suggest
that Shh-responsive cells might be both temporally and
spatially restricted. Dissection of ED7 limb buds into ante-
rior and posterior halves revealed that embryonic myo-
blasts, present only in the posterior half of the limb bud, are
Shh responsive. In contrast to myoblasts located in the
posterior limb bud, myoblasts in the anterior limb bud are
not responsive to Shh in culture, and do not alter myoD
expression patterns upon infection with RCAS-mGli-1 in
vivo. Together these data show that myoblasts in the
developing limb are spatially restricted in their responsive-
evelopment. Shh, expressed in the posterior region of the limb bud,
ss, allowing mitogens present to stimulate their proliferation. The
ed to express slow MyHC, resulting in ectopic myosin staining at
he pool of proliferating myoblasts and ultimately results in less
maintains primary myoblasts in an undifferentiated state for an






ens tness to Shh and that this restriction is a cell autonomous
). All rights reserved.
146 Bren-Mattison and Olwinproperty. Further support for this conclusion is provided by
the observation that no decreases in skeletal muscle mass
occur if only anterior limb tissue is infected with RCAS-
mGli-1. We consistently observed a greater effect of Shh
and mGli-1 on ventral muscle compared to that on dorsal
muscle. A similar observation was recently reported in the
shh2/2 mouse, where ventral muscle masses were com-
pletely lost, while some dorsal muscle masses were still
formed (Kruger et al., 2001). Thus, the activity of Shh
appears to preferentially, but not exclusively, affect ventral
muscle compared to dorsal muscle.
A detailed and thorough analysis of the development of
axial muscle in both the zebrafish (Blagden et al., 1997;
Lewis et al., 1999) and chicken embryo (Borycki et al., 1999)
points to a critical role for Shh as an inducer or a permissive
factor for development of slow twitch or epaxial skeletal
muscle fibers. In the absence of hedgehogs, slow axial
muscle MyHC does not form. Shh has also been reported to
affect the relative distribution of fast and slow axial skeletal
muscle precursors in the chicken embryo somite (Cann et
al., 1999; Nikovits et al., 2001) but no information is
available for the role of Shh on fiber-type specificity in the
hypaxial muscle precursors in the limb. In the present
study, we found that Shh preferentially inhibited differen-
tiation of hypaxial myoblasts that differentiate and then
express slow MyHC compared to myoblasts that will ex-
clusively express fast MyHC isoforms. Recent data suggest
that migratory myoblasts commit to express slow MyHC
prior to migration out of the somite (Nikovits et al., 2001).
Moreover, myoblast migration appears to occur in distinct
waves and it has been reported that myoblasts fated to
express slow MyHC upon differentiation migrate prior to
the myoblasts fated to express fast MyHC (Van Swearingen
and Lance-Jones, 1995). It is tempting to speculate that Shh
expressed in the early limb bud preferentially maintains the
slow MyHC precursor pool.
The distribution of myoblasts in early muscle masses
may not reflect the final position of myoblasts in differen-
tiated muscle fibers. Thus, the reason for specifying slow
verses fast MyHC in embryonic myoblasts is not clear.
Perhaps these myoblasts will form myofibers with distinct
responses to signaling events that later dictate the distribu-
tion of slow and fast MyHC in muscle tissue.
We propose a function for Shh in skeletal muscle devel-
opment (Fig. 13), which can account for the experimental
observations made in skeletal muscle of diverse vertebrate
organisms. This model predicts that: (i) inhibition of Shh
signaling would lead to enhanced differentiation or expres-
sion of muscle markers, yielding an eventual loss of skeletal
muscle mass due to a deficiency in slow MyHC fibers; and
(ii) augmentation of Shh signaling would lead to an initial
reduction in muscle differentiation or muscle markers
followed by an increase in skeletal muscle mass due to an
increase in the number of slow MyHC expressing fibers.
The confusion regarding the function of Shh for myoblasts
in the limb, and the trunk where Shh is reported to be an
inducer of muscle tissue, an activator of differentiation, or
© 2002 Elsevier Science (USAa proliferation factor may arise because of the relative
temporal differences when these experiments were con-
ducted and assayed. If Shh functions as a direct permissive
factor for a spatially restricted subset of slow MyHC pre-
cursors present in the hypaxial muscle of the limbs, as
indicated by these studies, the requirement for Shh in these
cells does not appear to affect fast MyHC hypaxial precur-
sors. These data are consistent with the interpretation that
the myoblasts fated to express either slow or fast MyHC are
fixed and that the extent of slow or fast fibers in primary
myotubes depends only on the size of the precursor pool.
The Shh-dependent increases we observed in skeletal
muscle mass in vivo appear to be exclusively due to
increases in the amount of slow MyHC. During develop-
ment it is unlikely that all of the effects observed are
attributed to Shh, since Indian hedgehog begins to be
expressed between ED5 and ED6 in the developing skeleton
and is in close proximity to the expanding skeletal muscu-
lature (Vortkamp et al., 1996). Future experiments are
directed toward understanding the relative contributions of
Shh and Ihh to the distribution of slow MyHC in developing
skeletal muscle tissue.
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